Adial director buys 36,378 pre-funded warrants
ADIAL PHARMACEUTICALS, INC. director Wendy B. Young purchased 36,378 Pre-Funded Warrants on June 12, 2026 in an open-market or private transaction at $2.7489 per warrant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ADIAL PHARMACEUTICALS, INC. director Wendy B. Young purchased 36,378 Pre-Funded Warrants on June 12, 2026 in an open-market or private transaction at $2.7489 per warrant. Each warrant is exercisable into one share of common stock at an exercise price of $0.001 per share.
The Pre-Funded Warrants have no expiration date and become exercisable after approval of the company’s stockholders. Exercise is limited by a 4.99% beneficial ownership cap, preventing the holder and affiliates from exceeding that ownership level after exercise. Following this transaction, Young directly holds 36,378 Pre-Funded Warrants.
Insider Trade Summary
Net Buyer: 36,378 shares
Net Buy
1 txn
Insider
Young Wendy B.
Role
Director
Bought
36,378 shs ($100K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Pre-funded Warrant | 36,378 | $2.7489 | $100K |
Holdings After Transaction:
Pre-funded Warrant — 36,378 contracts (Direct)
Footnotes (2)
- F1. Pursuant to the terms of that certain Pre-Funded Warrant to Purchase Common Stock, dated June 12, 2026, issued by the Issuer to the Reporting Person pursuant to a securities purchase agreement entered into by and among the Issuer, the Reporting Person and certain other parties on June 11, 2026.
- F2. The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after receiving approval of the Issuer's stockholders. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Key Figures
Pre-Funded Warrants purchased: 36,378 warrants
Purchase price per warrant: $2.7489 per warrant
Exercise price per underlying share: $0.001 per share
+3 more
6 metrics
Pre-Funded Warrants purchased
36,378 warrants
Open-market or private purchase on June 12, 2026
Purchase price per warrant
$2.7489 per warrant
Pre-Funded Warrant transaction
Exercise price per underlying share
$0.001 per share
Conversion/exercise price of Pre-Funded Warrants
Underlying common shares
36,378 shares
One share of common stock per warrant
Holdings after transaction
36,378 warrants
Total Pre-Funded Warrants directly held post-transaction
Beneficial ownership cap
4.99%
Maximum ownership allowed after warrant exercise
Key Terms
Pre-funded Warrant, securities purchase agreement, beneficially own, Pre-Funded Warrants, +1 more
5 terms
Pre-funded Warrant financial
"Pre-funded Warrant to Purchase Common Stock, dated June 12, 2026"
A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.
securities purchase agreement financial
"pursuant to a securities purchase agreement entered into by and among the Issuer"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
beneficially own financial
"would beneficially own more than 4.99% of the number of shares of common stock"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Pre-Funded Warrants financial
"The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants")"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
common stock outstanding financial
"number of shares of common stock outstanding immediately after giving effect to such exercise"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ADIL director Wendy B. Young report?
Wendy B. Young reported buying 36,378 Pre-Funded Warrants of Adial Pharmaceuticals. The transaction occurred on June 12, 2026 at a purchase price of $2.7489 per warrant, and she now directly holds 36,378 of these derivative securities.
What are the key terms of the ADIL Pre-Funded Warrants purchased?
Each Pre-Funded Warrant is exercisable into one share of Adial common stock at an exercise price of $0.001. The warrants have no expiration date and become exercisable after receiving approval of Adial’s stockholders, according to the disclosed footnotes.
Is there an ownership limit on exercising the ADIL Pre-Funded Warrants?
Yes. The filing states a holder may not exercise the Pre-Funded Warrants if, together with its affiliates, it would beneficially own more than 4.99% of Adial’s common stock outstanding immediately after the exercise, effectively capping post-exercise ownership.
How many ADIL Pre-Funded Warrants does Wendy B. Young hold after this transaction?
Following the reported purchase, Wendy B. Young directly holds 36,378 Pre-Funded Warrants. The filing shows these are derivative securities linked to an equal number of underlying Adial common shares, subject to the exercise terms and ownership limitation described.
At what price did Wendy B. Young buy the ADIL Pre-Funded Warrants?
She purchased the Pre-Funded Warrants at $2.7489 per warrant in an open-market or private transaction. Each warrant is linked to one underlying share with a separate $0.001 exercise price, which would apply if and when she exercises the warrants.
When do the ADIL Pre-Funded Warrants become exercisable?
The warrants become exercisable at any time after Adial Pharmaceuticals receives approval of its stockholders. Until that condition is met, they are not exercisable, even though they otherwise have no expiration date according to the filing’s footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates